Authors:
Kramer, L
Gendo, A
Madl, C
Mullen, KD
Kaminski-Russ, K
Sunder-Plassmann, G
Schaffer, A
Bauer, E
Roth, E
Ferenci, P
Citation: L. Kramer et al., A controlled study of sorbent suspension dialysis in chronic liver diseaseand hepatic encephalopathy, INT J ARTIF, 24(7), 2001, pp. 434-442
Authors:
Younossi, ZM
Mullen, KD
Zakko, W
Hodnick, S
Brand, E
Barnes, DS
Carey, WD
McCullough, AC
Easley, K
Boparai, N
Gramlich, T
Citation: Zm. Younossi et al., A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy, J HEPATOL, 34(1), 2001, pp. 128-133
Citation: A. Kyprianou et al., Focal neurological signs in cirrhotic patients with episodes of hepatic encephalopathy, AM J GASTRO, 96(2), 2001, pp. 273-274
Citation: Sa. Fulton et Kd. Mullen, Completion of upper endoscopic procedures despite paradoxical reaction to midazolam: A role for flumazenil?, AM J GASTRO, 95(3), 2000, pp. 809-811
Citation: Fn. Bashour et al., Prevalence of peripheral blood cytopenias (Hypersplenism) in patients withnonalcoholic chronic liver disease, AM J GASTRO, 95(10), 2000, pp. 2936-2939
Authors:
Keeffe, EB
Dusheiko, GM
James, SP
Mullen, KD
Everson, GT
Pimstone, NR
Donovan, J
Albert, D
Citation: Eb. Keeffe et al., Utility of hepatitis C virus serotypes in predicting response to treatmentof chronic hepatitis C, CYTOK CELL, 5(4), 1999, pp. 207-210
Authors:
Heathcote, EJL
James, S
Mullen, KD
Hauser, SC
Rosenblate, H
Albert, DG
Citation: Ejl. Heathcote et al., Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon, HEPATOLOGY, 30(2), 1999, pp. 562-566
Authors:
O'Connor, JB
Sondhi, SS
Mullen, KD
McCullough, AJ
Citation: Jb. O'Connor et al., A continuous quality improvement initiative reduces inappropriate prescribing of prophylactic antibiotics for endoscopic procedures, AM J GASTRO, 94(8), 1999, pp. 2115-2121